IDI1, a metabolic enzyme, interacts with cGAS, and TRIM41, an E3 ligase from hepatocellular carcinoma cells, promotes cGAS degradation, suggesting a role in innate immunity and a potential target for liver cancer treatment (70). This evidence concerns the gene CGAS and liver cancer.